Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

Tesla stock slipped on Tuesday after Bank of America said it sees shares fairly priced, with some risk to the downside. As Nvidia races to bring more of its next-gen chips online, CEO Jensen Huang ...

Jasper Therapeutics' SPOTLIGHT study reports 93% clinical response in cold urticaria and symptomatic dermographism. The 120mg dose showed 83% complete response and no severe adverse events.

Why Keysight Technologies Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ...

Japan Airlines Co. Ltd.-1.07% ¥1.08T ...